Perseus Proteomics Inc. (TYO:4882)
Japan
· Delayed Price · Currency is JPY 288.00
+55.00 (23.61%)
At close: Mar 9, 2026
Perseus Proteomics Revenue
Perseus Proteomics had revenue of 43.10M JPY in the quarter ending December 31, 2025, with 82.02% growth. This brings the company's revenue in the last twelve months to 140.41M, up 26.06% year-over-year. In the fiscal year ending March 31, 2025, Perseus Proteomics had annual revenue of 120.00M with 20.00% growth.
Revenue (ttm)
140.41M
Revenue Growth
+26.06%
P/S Ratio
30.25
Revenue / Employee
4.39M
Employees
32
Market Cap
4.25B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JCR Pharmaceuticals | 37.55B |
| Santen Pharmaceutical | 287.99B |
| Kyowa Kirin | 496.83B |
| Ono Pharmaceutical | 509.35B |
| Astellas Pharma | 2,060.61B |
| Daiichi Sankyo Company | 2,052.15B |
| Otsuka Holdings | 2,468.89B |
| Chugai Pharmaceutical | 1,257.94B |